α-KGDDs are implicated in cancer through multiple mechanisms. Dysregulated α-KGDD activity can lead to aberrant gene expression, altered cellular metabolism, and disrupted cellular differentiation. For instance, mutations in genes encoding α-KGDDs or alterations in α-KG levels have been associated with various cancers, including glioblastoma, leukemia, and renal cell carcinoma.
